This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Laboratorio Reig Jofre Crecimiento futuro

Future controles de criterios 4/6

Laboratorio Reig Jofre is forecasted to grow earnings and revenue by 26.6% and 5.5% per annum respectively. EPS is expected to grow by 26.4%. Return on equity is forecast to be 8.5% in 3 years.

Información clave

26.6%

Tasa de crecimiento de los beneficios

26.4%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Pharmaceuticals	14.6%
Tasa de crecimiento de los ingresos	5.5%
Rentabilidad financiera futura	8.5%
Cobertura de analistas	Low
Última actualización	n/a

Actualizaciones recientes sobre el crecimiento futuro

No hay actualizaciones

Recent updates

No hay actualizaciones

Previsiones de crecimiento de beneficios e ingresos

BME:RJF.D - Estimaciones futuras de los analistas y datos financieros pasados (EUR Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2024	291	14	17	35	1
12/31/2023	279	12	14	31	1
12/31/2022	261	7	4	19	1
12/31/2021	240	5	-5	14	N/A
9/30/2021	237	6	N/A	N/A	N/A
6/30/2021	234	6	9	26	N/A
3/31/2021	234	6	N/A	N/A	N/A
12/31/2020	234	6	7	19	N/A
9/30/2020	229	8	N/A	N/A	N/A
6/30/2020	229	6	-15	14	N/A
3/31/2020	219	6	N/A	N/A	N/A
12/31/2019	206	5	-19	12	N/A
9/30/2019	199	7	N/A	N/A	N/A
6/30/2019	188	9	-10	16	N/A
3/31/2019	188	9	N/A	N/A	N/A
12/31/2018	185	9	-6	15	N/A
9/30/2018	185	10	N/A	N/A	N/A
6/30/2018	179	9	-4	14	N/A
3/31/2018	175	9	N/A	N/A	N/A
12/31/2017	172	9	3	21	N/A
9/30/2017	164	5	N/A	N/A	N/A
6/30/2017	164	7	-6	8	N/A
3/31/2017	164	8	N/A	N/A	N/A
12/31/2016	161	8	-14	-1	N/A
9/30/2016	160	5	N/A	N/A	N/A
6/30/2016	159	5	-4	8	N/A
3/31/2016	156	5	N/A	N/A	N/A
12/31/2015	157	9	2	13	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: RJF.D's forecast earnings growth (26.6% per year) is above the savings rate (0.9%).

Beneficios vs. Mercado: RJF.D's earnings (26.6% per year) are forecast to grow faster than the Spanish market (10.3% per year).

Beneficios de alto crecimiento: RJF.D's earnings are expected to grow significantly over the next 3 years.

Ingresos vs. Mercado: RJF.D's revenue (5.5% per year) is forecast to grow faster than the Spanish market (3% per year).

Ingresos de alto crecimiento: RJF.D's revenue (5.5% per year) is forecast to grow slower than 20% per year.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: RJF.D's Return on Equity is forecast to be low in 3 years time (8.5%).